Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Mary Glenn Fowler(Johns Hopkins University), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Francis Martinson, Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Raziya Bobat(Jacobi Medical Center), Devasena Gnanashanmugam(Johns Hopkins University), Avy Violari(University of the Witwatersrand), James McIntyre(Perinatal HIV Research Unit), Renate Strehlau(Johns Hopkins University), Anne Coletti(Family Health International 360), David E. Shapiro(Intercept Pharmaceuticals (United States)), Pendo Mlay(Johns Hopkins University), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Karin L. Klingman(National Institutes of Health), Amy James Loftis(Infectious Disease Consultants), Maxensia Owor(Makerere University), Min Qin(National Institutes of Health), Judith S. Currier(University of California, Los Angeles), Lynette Purdue(National Institutes of Health), George K. Siberry(Columbia University Irving Medical Center), Gerhard Theron(Stellenbosch University), Terence Fenton(GTx (United States)), Ramesh Bhosale(B.J. Medical College), Renee Browning(Johns Hopkins University), Susan A. Fiscus(University of North Carolina at Chapel Hill), Tsungai Chipato(University of Zimbabwe-University of California San Francisco), Michael Basar(Johns Hopkins University), Patricia M. Flynn(St. Jude Children's Research Hospital)
Cited by 4
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k